Division of Gastroenterology, Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.
Department of Internal Medicine, Dongguk University Ilsan Hospital, Goyang, Korea.
Gut Liver. 2022 Nov 15;16(6):899-906. doi: 10.5009/gnl210466. Epub 2022 Aug 1.
BACKGROUND/AIMS: This study aimed to determine changes in endoscopist-driven sedation practices 5 years after the first nationwide survey in 2014 by the Korean Society of Gastrointestinal Endoscopy (KSGE).
A 59-item survey covering current practices was electronically mailed to all members of the KSGE in 2019.
In total, 955 (12.8%) out of 7,486 questionnaires were returned. A total of 738 (77.7%) out of 955 respondents attended dedicated sedation education programs. The American Society of Anesthesiologists class was recorded by 464 (51.2%) out of 907 respondents. The recording rate was higher in respondents who completed sedation education (p=0.014) and worked in general or tertiary hospitals (p<0.001). Compared to that reported in the previous survey, the reported use of propofol was higher in 2019. The respondents had higher satisfaction scores for propofol-based sedation compared with midazolam monotherapy (p<0.001). The rates of oxygen supplementation (p<0.001) and oxygen saturation level monitoring (p<0.001) during sedative endoscopy were higher in 2019 than in the previous survey. A total of 876 (98.4%) out of 890 respondents reported a separate recovery bay, and 615 (70.5%) out of 872 respondents reported that personnel were assigned solely to the recovery bay.
Endoscopist-driven sedation and monitoring practices in 2019 were significantly different than those in 2014. The respondents favored propofol-based sedation and utilized oxygen supplementation and monitoring of O saturation more frequently in 2019 than in 2014.
背景/目的:本研究旨在确定在韩国胃肠内镜学会(KSGE)于 2014 年进行首次全国调查后的 5 年内,内镜医师主导的镇静实践发生了哪些变化。
2019 年,向 KSGE 的所有成员发送了一份涵盖当前实践的 59 项调查。
共收回 7486 份问卷中的 955 份(12.8%)。955 名受访者中有 738 名(77.7%)参加了专门的镇静教育计划。907 名受访者中有 464 名(51.2%)记录了美国麻醉师协会的分类。在完成镇静教育的受访者(p=0.014)和在普通或三级医院工作的受访者中,记录率更高(p<0.001)。与前一次调查相比,报告的 2019 年丙泊酚使用率更高。与咪达唑仑单一疗法相比,受访者对基于丙泊酚的镇静有更高的满意度评分(p<0.001)。2019 年镇静内镜期间氧气补充(p<0.001)和氧饱和度监测(p<0.001)的比例高于前一次调查。890 名受访者中有 876 名(98.4%)报告有单独的复苏舱,872 名受访者中有 615 名(70.5%)报告有人专门负责复苏舱。
2019 年内镜医师主导的镇静和监测实践与 2014 年有显著差异。与 2014 年相比,受访者在 2019 年更倾向于使用基于丙泊酚的镇静,并更频繁地使用氧气补充和监测氧饱和度。